Predictive effect of molecular and clinical characteristics for the OS and PFS efficacy of anti-PD-1/PD-L1 immunotherapy in patients with NSCLC: a meta-analysis and systematic review

OBJECTIVE: To evaluate the predictive effect of molecular and clinical characteristics for the efficacy of anti-programmed cell death 1 (PD-1)/programmed cell death ligand-1 (PD-L1) immunotherapy in patients with non-small cell lung cancer (NSCLC). DESIGN: Systematic review and meta-analysis. SETTIN...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Rui, Zhao, Feng, Wang, Liqian, Shan, Jikang, Wang, Xianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719178/
http://dx.doi.org/10.1136/bmjopen-2020-047663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719178/
http://dx.doi.org/10.1136/bmjopen-2020-047663

Ejemplares similares